# Clustering Approach 6 : MRNASEQ_CHIERARCHICAL
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.407327126024549	Range of duration = 8.65 to 131.08, nDeath = 14, nCensor = 7
2	AGE	ANOVA	0.968305379185865	Range of values = 32 to 87, Mean = 59.4286, StdDev = 13.6915
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.557825400371075	nTypes = 3 (DISTANT METASTASIS/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 3/4/14
4	GENDER	Fisher's exact test	0.999999999999993	nTypes = 2 (FEMALE/MALE), nPatients = 11/10
5	LYMPH.NODE.METASTASIS	Chi-square test	0.273991288544395	nTypes = 6 (N0/N1/N1A/N1B/N2B/N3), nPatients = 11/1/1/3/1/2, nMissing = 2
6	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 21
7	NEOPLASM.DISEASESTAGE	Chi-square test	0.165445928738343	nTypes = 9 (STAGE I/STAGE IA/STAGE II/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC), nPatients = 4/1/1/2/3/1/1/1/4, nMissing = 3